Biorex Research and Development Co. RT, CytRx deal

CYTR acquired the clinical and pharmaceutical assets of Biorex for $3 million in cash. The deal brings

Read the full 172 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE